This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why Nov Inc. (NOV) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Should You Invest in the First Trust Energy AlphaDEX ETF (FXN)?
by Zacks Equity Research
Sector ETF report for FXN
Here's Why Nov Inc. (NOV) is a Strong Growth Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Nov Inc. (NOV) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Nov Inc. (NOV) is a Top Growth Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
NOV Q2 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
NOV expects a flat or low single-digit revenue growth year over year, with adjusted EBITDA between $270 million and $305 million for the third quarter of 2024.
Nov Inc. (NOV) Reports Q2 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Nov Inc. (NOV) give insight into how the company performed in the quarter ended June 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nov Inc. (NOV) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 62.86% and 1.98%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Factors You Need to Know Ahead of NOV Q2 Earnings Release
by Zacks Equity Research
NOV is anticipated to have generated higher revenues from the year-ago period's level. However, it is expected to have recorded a lower bottom line due to rising costs.
Climb Global (CLMB) Moves 8.5% Higher: Will This Strength Last?
by Zacks Equity Research
Climb Global (CLMB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Is NOV (NOV) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Nov Inc. (NOV) is a Top-Ranked Value Stock: Should You Buy?
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Why Nov Inc. (NOV) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is John Hancock Multifactor Small Cap ETF (JHSC) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for JHSC
Should John Hancock Multifactor Small Cap ETF (JHSC) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for JHSC
Here's Why Nov Inc. (NOV) is a Strong Value Stock
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
NOV Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
by Zacks Equity Research
NOV expects consolidated revenues to grow in the mid-single percentage range, with adjusted EBITDA in the range of $1.10-$1.25 billion, for full year 2024.
Nov Inc. (NOV) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Nov Inc. (NOV) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Nov Inc. (NOV) Tops Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Nov Inc. (NOV) delivered earnings and revenue surprises of 11.11% and 2.37%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Trane Technologies (TT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Trane Technologies (TT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Nov Inc. (NOV) Q1 Earnings Expected to Decline
by Zacks Equity Research
Nov Inc. (NOV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arcosa (ACA) Buys Ameron, Expands Infrastructure Portfolio
by Zacks Equity Research
Arcosa (ACA) bolsters its infrastructure solutions through the Ameron acquisition.
Should You Invest in the SPDR S&P Oil & Gas Equipment & Services ETF (XES)?
by Zacks Equity Research
Sector ETF report for XES